Aging · 2023 · 13 citations · 20 references
MedicineMolecular BiologyOncologyChemotherapyGene ExpressionMolecular OncologyBiliary Tract CancerCancer Cell SignalingCancer ProgressionCancer TranscriptomicsMalignant NeoplasmsTherapeutic ResistanceCancer-related Noncoding Rna FunctionDual-luciferase AssaysLuciferase Reporter AssaysLuciferase ReportersMicrorna In CancerMicrorna Regulation In CancerMolecular Drug ResistanceTumor Resistance
BACKGROUND: LncRNA is an important regulatory factor in the human genome. We aim to explore the roles of LncFALEC and miR-20a-5p/SHOC2 axis on the proliferation, migration, and Fluorouracil (5-FU) resistance of cholangiocarcinoma (CCA). METHODS: In this study, the expression of FALEC and miR-20a-5p in CCA tissues and cell lines (HuCCT1, QBC939, and Huh-28) was detected by RT-qPCR. The FALEC in 5-FU-resistant CCA cell lines (QBC939-R, Huh-28-R) was knocked down to evaluate its effects on cell proliferation, migration, invasion, and drug resistance. RESULTS: Our analysis showed that compared with the adjacent non-tumor tissues, FALEC was significantly higher in the CCA tissues and even higher in the samples from 5-FU-resistant patients. Knockdown FALEC increased the sensitivity of 5-FU and decreased migration and invasion of CCA cells. Dual luciferase reporter confirmed that FALEC sponges miR-20a-5p and down-regulated its expression. Moreover, SHOC2 leucine-rich repeat scaffold protein (SHOC2) was the target gene of miR-20a-5p. We found overexpression of FALEC (FALEC-OE) increased resistance of CCA cells to 5-FU significantly, which might contribute to increased SHOC2 expression and activation of the ERK1/2 signaling pathway. CONCLUSIONS: by regulating the miR-20a-5p/SHOC2 axis and participating in 5-FU resistance by mediating the ERK1/2 signaling pathway.
20
Laura M. Selfors, Jennifer L. Schutzman, Christina Z. Borland et al. · Proceedings of the National Academy of Sciences · 1998 · 114 citations · Full text
Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers
Rita Sulahian, Jason J. Kwon, Katherine H. Walsh et al. · Cell Reports · 2019 · 93 citations · Full text
Life Sciences, Genetics, Oncology +17